Literature DB >> 19532067

Herpes simplex virus type 2 and syphilis infections with HIV: an evolving synergy in transmission and prevention.

Aaron Ar Tobian1, Thomas C Quinn.   

Abstract

PURPOSE OF REVIEW: Herpes simplex virus type 2 (HSV-2) and syphilis are associated with HIV infection. The purpose of this review is to summarize the advances in the relationship of HSV-2 and syphilis with HIV, highlighting intervention trials to prevent HIV acquisition and transmission. RECENT
FINDINGS: HIV acquisition has often been linked to genital ulcers due to HSV-2 and syphilis. The latest pathophysiological studies have continued to elucidate the relationship between HSV-2, syphilis and HIV, establishing that both syphilitic and HSV-2-infected tissue have increased numbers of chemokine receptor 5-expressing T cells, and several models have further emphasized the viral synergy between HSV-2 and HIV. In clinical trials, HSV suppressive therapy decreased HIV RNA levels that might affect transmission, but two trials have failed to prevent HIV acquisition. Male circumcision, however, prevents both HIV and HSV-2 acquisition.
SUMMARY: Genital ulcers from HSV-2 and syphilis are associated with HIV acquisition. The exact role for these HIV cofactors is still unknown and exemplified by the failure of HSV suppressive therapy to decrease HIV acquisition. Male circumcision, however, reduces HSV-2 acquisition. With several HSV suppressive trials to prevent HIV transmission and disease progression currently ongoing, the future promises to provide more critical information for the control of HIV infection.

Entities:  

Mesh:

Year:  2009        PMID: 19532067      PMCID: PMC2752434          DOI: 10.1097/COH.0b013e32832c1881

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  57 in total

Review 1.  Herpes simplex virus and HIV-1: deciphering viral synergy.

Authors:  Philippe Van de Perre; Michel Segondy; Vincent Foulongne; Abdoulaye Ouedraogo; Issouf Konate; Jean-Marie Huraux; Philippe Mayaud; Nicolas Nagot
Journal:  Lancet Infect Dis       Date:  2008-08       Impact factor: 25.071

2.  Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

Authors:  Connie Celum; Anna Wald; James Hughes; Jorge Sanchez; Stewart Reid; Sinead Delany-Moretlwe; Frances Cowan; Martin Casapia; Abner Ortiz; Jonathan Fuchs; Susan Buchbinder; Beryl Koblin; Sheryl Zwerski; Scott Rose; Jing Wang; Lawrence Corey
Journal:  Lancet       Date:  2008-06-21       Impact factor: 79.321

3.  Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract.

Authors:  Jeanne S Sheffield; George D Wendel; Donald D McIntire; Michael V Norgard
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

Review 4.  Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis.

Authors:  Kimberly A Powers; Charles Poole; Audrey E Pettifor; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2008-08-04       Impact factor: 25.071

5.  Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients.

Authors:  Khalil G Ghanem; Richard D Moore; Anne M Rompalo; Emily J Erbelding; Jonathan M Zenilman; Kelly A Gebo
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

6.  Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.

Authors:  Prameet M Sheth; Sherzana Sunderji; Lucy Y Y Shin; Anuradha Rebbapragada; Sanja Huibner; Joshua Kimani; Kelly S Macdonald; Elizabeth Ngugi; Job J Bwayo; Stephen Moses; Colin Kovacs; Mona Loutfy; Rupert Kaul
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

7.  Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.

Authors:  N Nagot; A Ouedraogo; I Konate; H A Weiss; V Foulongne; M C Defer; A Sanon; P Becquart; M Segondy; A Sawadogo; P Van de Perre; P Mayaud
Journal:  J Infect Dis       Date:  2008-07-15       Impact factor: 5.226

8.  Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.

Authors:  Jared M Baeten; Lara B Strick; Aldo Lucchetti; William L H Whittington; Jorge Sanchez; Robert W Coombs; Amalia Magaret; Anna Wald; Lawrence Corey; Connie Celum
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

9.  Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.

Authors:  Deborah Watson-Jones; Helen A Weiss; Mary Rusizoka; John Changalucha; Kathy Baisley; Kokugonza Mugeye; Clare Tanton; David Ross; Dean Everett; Tim Clayton; Rebecca Balira; Louise Knight; Ian Hambleton; Jerome Le Goff; Laurent Belec; Richard Hayes
Journal:  N Engl J Med       Date:  2008-03-12       Impact factor: 91.245

10.  Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.

Authors:  Laith J Abu-Raddad; Amalia S Magaret; Connie Celum; Anna Wald; Ira M Longini; Steven G Self; Lawrence Corey
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more
  45 in total

1.  Human immunodeficiency virus test-seeking blood donors in a large blood bank in São Paulo, Brazil.

Authors:  Thelma Goncalez; Ester Sabino; Nanci Sales; Yea-Hung Chen; Dalton Chamone; Michael Busch; Edward Murphy; Brian Custer; Willi McFarland
Journal:  Transfusion       Date:  2010-04-30       Impact factor: 3.157

2.  Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda.

Authors:  Aaron A R Tobian; Godfrey Kigozi; Andrew D Redd; David Serwadda; Xiangrong Kong; Amy Oliver; Fred Nalugoda; Thomas C Quinn; Ronald H Gray; Maria J Wawer
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

3.  Does offering human immunodeficiency virus testing at the time of blood donation reduce transfusion transmission risk and increase disclosure counseling? Results of a randomized controlled trial, São Paulo, Brazil.

Authors:  Thelma T Goncalez; Paula F Blatyta; Fernanda M Santos; Sandra Montebello; Sandra P D Esposti; Fatima N Hangai; Nanci A Salles; Alfredo Mendrone; Hong-Ha M Truong; Ester C Sabino; Willi McFarland
Journal:  Transfusion       Date:  2015-02-03       Impact factor: 3.157

4.  Viral kinetics of genital herpes: a molecular probe into host-viral interactions.

Authors:  Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

5.  Performance evaluation of the Elecsys syphilis assay for the detection of total antibodies to Treponema pallidum.

Authors:  Martin Enders; Andrea Hunjet; Michael Gleich; Roland Imdahl; Annelies Mühlbacher; Harald Schennach; Kriangsak Chaiwong; Tasanee Sakuldamrongpanich; Ajda Turhan; Rüchan Sertöz; Eva Wolf; Wolfgang Mayer; Chuanmin Tao; Lan Lan Wang; Simona Semprini; Vittorio Sambri
Journal:  Clin Vaccine Immunol       Date:  2014-10-29

Review 6.  Mammalian alphaherpesvirus miRNAs.

Authors:  Igor Jurak; Anthony Griffiths; Donald M Coen
Journal:  Biochim Biophys Acta       Date:  2011-06-28

7.  Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Salaam Semaan
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

8.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (abridged version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

9.  Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).

Authors:  Sumit Dave; Kourosh Afshar; Luis H Braga; Peter Anderson
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

10.  HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5.

Authors:  M Reza Zariffard; Mohammed Saifuddin; Alison Finnegan; Gregory T Spear
Journal:  AIDS Res Hum Retroviruses       Date:  2009-11       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.